Farallon Capital Management LLC decreased its position in Quanterix Co. (NASDAQ:QTRX – Free Report) by 83.0% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 80,000 shares of the company’s stock after selling 391,000 shares during the period. Farallon Capital Management LLC owned about 0.21% of Quanterix worth $1,057,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Lord Abbett & CO. LLC boosted its position in shares of Quanterix by 22.9% in the first quarter. Lord Abbett & CO. LLC now owns 1,757,153 shares of the company’s stock worth $41,398,000 after buying an additional 326,876 shares during the period. Superstring Capital Management LP purchased a new position in Quanterix during the 4th quarter valued at about $1,962,000. Williams Jones Wealth Management LLC. acquired a new position in shares of Quanterix in the 1st quarter valued at about $1,327,000. Easterly Investment Partners LLC lifted its position in shares of Quanterix by 551.1% in the first quarter. Easterly Investment Partners LLC now owns 78,734 shares of the company’s stock worth $1,855,000 after purchasing an additional 66,642 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in shares of Quanterix by 15.6% during the fourth quarter. Dimensional Fund Advisors LP now owns 974,111 shares of the company’s stock worth $26,635,000 after purchasing an additional 131,195 shares during the period. 86.48% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity
In other news, Director David R. Walt acquired 47,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 20th. The stock was acquired at an average cost of $13.29 per share, with a total value of $624,630.00. Following the acquisition, the director now owns 1,487,342 shares in the company, valued at $19,766,775.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 6.90% of the company’s stock.
Analyst Ratings Changes
View Our Latest Analysis on Quanterix
Quanterix Trading Down 4.5 %
Shares of NASDAQ:QTRX opened at $13.89 on Tuesday. Quanterix Co. has a 1 year low of $10.50 and a 1 year high of $29.70. The firm has a fifty day moving average price of $13.41 and a 200 day moving average price of $16.18. The stock has a market capitalization of $531.57 million, a PE ratio of -14.47 and a beta of 1.36.
Quanterix (NASDAQ:QTRX – Get Free Report) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.02). Quanterix had a negative net margin of 30.71% and a negative return on equity of 11.52%. The company had revenue of $34.38 million for the quarter, compared to analyst estimates of $34.19 million. During the same period in the prior year, the company posted ($0.16) EPS. On average, sell-side analysts forecast that Quanterix Co. will post -0.88 earnings per share for the current fiscal year.
Quanterix Company Profile
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.
See Also
- Five stocks we like better than Quanterix
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- The Average 401k Balance by Age Explained
- The Most Important Warren Buffett Stock for Investors: His Own
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Find and Profitably Trade Stocks at 52-Week Lows
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Want to see what other hedge funds are holding QTRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quanterix Co. (NASDAQ:QTRX – Free Report).
Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.